サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1611036

コレラワクチンの市場規模、シェア、分析レポート：タイプ別、製品別、流通チャネル別、地域別、セグメント別予測、2025年～2030年

Cholera Vaccines Market Size, Share & Analysis Report By Type, By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
コレラワクチンの市場規模、シェア、分析レポート：タイプ別、製品別、流通チャネル別、地域別、セグメント別予測、2025年～2030年
出版日: 2024年11月14日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

コレラワクチン市場の成長と動向

Grand View Research, Inc.の最新レポートによると、コレラワクチンの世界市場規模は2030年までに1億6,340万米ドルに達する見込みで、2025～2030年のCAGRは10.0%です。

コレラに関するイニシアチブの増加と認知度の向上が市場成長の主要要因です。

コレラに罹患している地域の開発政府は、強力な公衆衛生と衛生インフラを開発することによって、この病気を撲滅しようと努力しています。2013年2月、ハイチ政府は10年間の国家コレラ撲滅計画を開始しました。国連機関はコレラ撲滅を国連の重要な優先課題としており、48時間以内に警報に対応する仕組みの確立、家庭訪問、啓発キャンペーンなどを通じてハイチ政府を支援しています。

さらに、アフリカでは疫学調査や人類学調査など、さまざまな研究プロジェクトや調査が行われています。現在進行中の研究としては、流行の拡散メカニズムを理解し、アウトブレイクを予測するために、水のサンプルからコレラ菌（Vibrio cholerae）を検出する迅速診断テストを使用することなどがあります。コレラプラットフォームは、世界コレラ対策委員会（GTFCC）のWASH作業部会と協力しています。この団体は、コレラ病の制圧と予防のためのケーススタディの実施方法を開発することを目的としています。

コレラワクチン市場レポートハイライト

  • コレラワクチンの世界市場規模は2024年に9,390万米ドルとなり、2025～2030年にかけてCAGR 10.0%で成長すると予測されます。
  • 製品別では、2024年にDukoralワクチンが市場を独占しました。この優位性は、2004年以来、このワクチンがこの病気の予防に良好な結果をもたらしていることに起因しています。Dukoralは安全で安定していると考えられています。
  • Vaxchoraセグメントは、単回接種や副作用の軽減など、このワクチンに関連する利点により、予測期間中に有利なCAGRを示すと予想されます。
  • 北米は、罹患率の増加や、この病気とワクチン接種に関する認識を高めるためのイニシアチブの高まりなどの要因により、2024年に最大のシェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 コレラワクチン市場の変数、動向、範囲

  • 市場イントロダクション/系統展望
  • 市場規模と成長展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • コレラワクチン市場分析ツール
    • ポーターの分析
    • PESTEL分析

第4章 コレラワクチン市場：タイプ別、推定・動向分析

  • タイプ市場シェア、2024年と2030年
  • タイプセグメントダッシュボード
  • 市場規模と予測と動向分析、タイプ別、2018～2030年
  • 組み換えBサブユニットを含む全細胞V. Cholerae O1
  • 殺菌済み経口O1とO139

第5章 コレラワクチン市場：製品別、推定・動向分析

  • 製品市場シェア、2024年と2030年
  • 製品セグメントダッシュボード
  • 市場規模と予測と動向分析、製品別、2018～2030年
  • Vaxchora
  • Dukoral
  • Shanchol
  • その他

第6章 コレラワクチン市場：流通チャネル別、推定・動向分析

  • 流通チャネル市場シェア、2024年と2030年
  • 流通チャネルセグメントダッシュボード
  • 市場規模と予測と動向分析、流通チャネル別、2018～2030年
  • 病院薬局
  • 小売薬局
  • その他

第7章 コレラワクチン市場：地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 市場規模と予測動向分析、2018～2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • Valneva SE
    • Sanofi SA
    • Emergent BioSolutions Inc.
    • PaxVax Inc.
    • EuBiologics Co., Ltd.
    • Shantha BIoTechnics Limited
    • Hilleman Laboratories
    • Astellas Pharma Inc.
    • Incepta Vaccine Ltd.
    • VabIoTech
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Cholera Vaccine Market, by Region, 2018 - 2030 (USD Million)
  • Table 4. Global Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 5. Global Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 6. Global Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 7. North America Cholera Vaccine Market, by Country, 2018 - 2030 (USD Million)
  • Table 8. North America Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 9. North America Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 10. North America Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 11. U.S. Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 12. U.S. Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 13. U.S. Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 14. Canada Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 15. Canada Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 16. Canada Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 17. Mexico Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 18. Mexico Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 19. Mexico Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20. Europe Cholera Vaccine Market, by Country, 2018 - 2030 (USD Million)
  • Table 21. Europe Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 22. Europe Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 23. Europe Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24. UK Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 25. UK Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 26. UK Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 27. Germany Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 28. Germany Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 29. Germany Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30. France Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 31. France Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 32. France Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 33. Italy Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 34. Italy Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 35. Italy Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36. Spain Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 37. Spain Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 38. Spain Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 39. Denmark Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 40. Denmark Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 41. Denmark Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42. Sweden Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 43. Sweden Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 44. Sweden Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 45. Norway Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 46. Norway Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 47. Norway Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific Cholera Vaccine Market, by Country, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 51. Asia Pacific Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52. Japan Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 53. Japan Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 54. Japan Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 55. China Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 56. China Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 57. China Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58. India Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 59. India Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 60. India Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 61. Australia Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 62. Australia Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 63. Australia Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 64. South Korea Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 65. South Korea Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 66. South Korea Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 67. Thailand Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 68. Thailand Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 69. Thailand Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 70. Latin America Cholera Vaccine Market, by Country, 2018 - 2030 (USD Million)
  • Table 71. Latin America Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 72. Latin America Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 73. Latin America Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 74. Brazil Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 75. Brazil Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 76. Brazil Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 77. Argentina Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 78. Argentina Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 79. Argentina Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa Cholera Vaccine Market, by Country, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 83. Middle East & Africa Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 84. South Africa Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 85. South Africa Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 86. South Africa Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 89. Saudi Arabia Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 90. UAE Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 91. UAE Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 92. UAE Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 93. Kuwait Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
  • Table 94. Kuwait Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
  • Table 95. Kuwait Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Cholera Vaccine Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Segment Outlook (USD Million)
  • Fig. 10 Competitive Landscape
  • Fig. 11 Cholera Vaccine Market Dynamics
  • Fig. 12 Cholera Vaccine Market: Porter's Five Forces Analysis
  • Fig. 13 Cholera Vaccine Market: Pestle Analysis
  • Fig. 14 Cholera Vaccine Market: Type Segment Dashboard
  • Fig. 15 Cholera Vaccine Market: Type Market Share Analysis, 2024 & 2030
  • Fig. 16 Whole Cell V. Cholerae O1 with Recombinant B-subunit (USD Million)
  • Fig. 17 Killed Oral O1 and O139 (USD Million)
  • Fig. 18 Cholera Vaccine Market: Product Segment Dashboard
  • Fig. 19 Cholera Vaccine Market: Product Market Share Analysis, 2024 & 2030
  • Fig. 20 Vaxchora Market, 2018 - 2030 (USD Million)
  • Fig. 21 Dukoral Market, 2018 - 2030 (USD Million)
  • Fig. 22 Shanchol Market, 2018 - 2030 (USD Million)
  • Fig. 23 Other Products Market, 2018 - 2030 (USD Million)
  • Fig. 24 Cholera Vaccine Market: Distribution Channel Segment Dashboard
  • Fig. 25 Cholera Vaccine Market: Distribution Channel Market Share Analysis, 2024 & 2030
  • Fig. 26 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
  • Fig. 27 Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • Fig. 28 Others Market, 2018 - 2030 (USD Million)
  • Fig. 29 Regional Marketplace: Key Takeaways
  • Fig. 30 North America Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Country Dynamics
  • Fig. 32 U.S. Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Country Dynamics
  • Fig. 34 Canada Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico Country Dynamics
  • Fig. 36 Mexico Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 38 UK Country Dynamics
  • Fig. 39 UK Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany Country Dynamics
  • Fig. 41 Germany Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 42 France Country Dynamics
  • Fig. 43 France Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy Country Dynamics
  • Fig. 45 Italy Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain Country Dynamics
  • Fig. 47 Spain Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark Country Dynamics
  • Fig. 49 Denmark Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden Country Dynamics
  • Fig. 51 Sweden Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway Country Dynamics
  • Fig. 53 Norway Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 55 Japan Country Dynamics
  • Fig. 56 Japan Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 57 China Country Dynamics
  • Fig. 58 China Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 59 India Country Dynamics
  • Fig. 60 India Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 61 Australia Country Dynamics
  • Fig. 62 Australia Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea Country Dynamics
  • Fig. 64 South Korea Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 65 Thailand Country Dynamics
  • Fig. 66 Thailand Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 67 Latin America Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 68 Brazil Country Dynamics
  • Fig. 69 Brazil Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 70 Argentina Country Dynamics
  • Fig. 71 Argentina Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 72 MEA Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 73 South Africa Country Dynamics
  • Fig. 74 South Africa Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 75 Saudi Arabia Country Dynamics
  • Fig. 76 Saudi Arabia Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 77 UAE Country Dynamics
  • Fig. 78 UAE Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 79 Kuwait Country Dynamics
  • Fig. 80 Kuwait Cholera Vaccine Market, 2018 - 2030 (USD Million)
  • Fig. 81 Company Categorization
  • Fig. 82 Company Market Position Analysis
  • Fig. 83 Strategic Framework
目次
Product Code: GVR-1-68038-069-9

Cholera Vaccines Market Growth & Trends:

The global cholera vaccines market size is expected to reach USD 163.4 million by 2030, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 10.0% from 2025 to 2030. Increase in number of initiatives and rising awareness about cholera are major factors contributing toward market growth.

Governments in regions affected by cholera are striving to eliminate the disease by developing a strong public health and sanitation infrastructure. In February 2013, the Government of Haiti launched a 10-year National Cholera Elimination Plan. The United Nations Organization has made elimination of cholera a key UN priority and offers support to the Haitian Government by establishing a mechanism to respond to an alert within 48 hours, household visits, and sensitization campaigns.

Furthermore, various research projects and studies, such as epidemiological and anthropological studies, are being conducted in Africa. Ongoing studies include using rapid diagnostics tests to detect Vibrio cholerae in samples of water to understand epidemic diffusion mechanisms and anticipate outbreaks. The Cholera Platform is working with the Global Task Force for Cholera Control (GTFCC) WASH working group. This association aims to develop a method for conducting case studies to control and prevent the disease.

Cholera Vaccines Market Report Highlights:

  • The global cholera vaccine market size was valued at USD 93.9 million in 2024 and is anticipated to grow at a CAGR of 10.0% from 2025 to 2030
  • By product, Dukoral vaccine dominated the market in 2024. The dominance can be attributed to the positive outcomes of this vaccine in preventing the disease since 2004. Dukoral is considered to be safe and stable
  • The Vaxchora segment is expected to exhibit a lucrative CAGR over the forecast period owing to benefits associated with the vaccine, such as single dose immunization and reduced adverse effects
  • North America held the largest share in 2024 due to factors such as increasing incidence and growing initiatives for raising awareness about the disease and vaccination

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Cholera Vaccine Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Cholera Vaccine Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining Power of the Suppliers
      • 3.4.1.2. Bargaining Power of the Buyers
      • 3.4.1.3. Threats of Substitution
      • 3.4.1.4. Threats from New Entrants
      • 3.4.1.5. Competitive Rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political Landscape
      • 3.4.2.2. Economic and Social Landscape
      • 3.4.2.3. Technological Landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape

Chapter 4. Cholera Vaccine Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Whole Cell V. Cholerae O1 with Recombinant B-subunit
    • 4.4.1. Whole Cell V. Cholerae O1 with Recombinant B-subunit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Killed Oral O1 and O139
    • 4.5.1. Killed Oral O1 and O139 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Cholera Vaccine Market: Product Estimates & Trend Analysis

  • 5.1. Product Market Share, 2024 & 2030
  • 5.2. Product Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Vaxchora
    • 5.4.1. Vaxchora Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Dukoral
    • 5.5.1. Dukoral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Shanchol
    • 5.6.1. Shanchol Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Other Products
    • 5.7.1. Other Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Cholera Vaccine Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2030
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 6.4. Hospital Pharmacy
    • 6.4.1. Hospital Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Retail Pharmacy
    • 6.5.1. Retail Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Cholera Vaccine Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Denmark Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Sweden Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Norway Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. China Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Japan
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. Japan Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. Australia Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. South Korea Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Valneva SE
      • 8.5.1.1. Participant's Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Recent Developments/ Strategic Initiatives
    • 8.5.2. Sanofi S.A.
      • 8.5.2.1. Participant's Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Recent Developments/ Strategic Initiatives
    • 8.5.3. Emergent BioSolutions Inc.
      • 8.5.3.1. Participant's Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Recent Developments/ Strategic Initiatives
    • 8.5.4. PaxVax Inc.
      • 8.5.4.1. Participant's Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Recent Developments/ Strategic Initiatives
    • 8.5.5. EuBiologics Co., Ltd.
      • 8.5.5.1. Participant's Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Recent Developments/ Strategic Initiatives
    • 8.5.6. Shantha Biotechnics Limited
      • 8.5.6.1. Participant's Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Recent Developments/ Strategic Initiatives
    • 8.5.7. Hilleman Laboratories
      • 8.5.7.1. Participant's Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Recent Developments/ Strategic Initiatives
    • 8.5.8. Astellas Pharma Inc.
      • 8.5.8.1. Participant's Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Recent Developments/ Strategic Initiatives
    • 8.5.9. Incepta Vaccine Ltd.
      • 8.5.9.1. Participant's Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Recent Developments/ Strategic Initiatives
    • 8.5.10. Vabiotech
      • 8.5.10.1. Participant's Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Recent Developments/ Strategic Initiatives